Paperpal Prime Logo

Infectious Agents and Cancer : Impact Factor & More

eISSN: 1750-9378pISSN: 1750-9378
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Infectious Agents and Cancer

Infectious Agents and Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2490 | USD 2990 | GBP 2190
Publication Time17
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAfrican Organization for Research and Training on Cancer (AORTIC)
FrequencyContinuous publication
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Infectious Agents and Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Infectious Agents and Cancer

Mechanistic interactions between Plasmodium falciparum and Epstein-Barr virus in endemic Burkitt Lymphoma pathogenesis: a narrative review (2010-2026).
  • 15 Jul 2026
  • Infectious agents and cancer
HIV-associated malignancies in Tunisia: a 30-year retrospective cohort study from a North African perspective.
  • 14 Jul 2026
  • Infectious agents and cancer
Diverse non-vaccine high-risk HPV genotypes in rural Kerala: implications for cervical cancer prevention in an underserved population.
  • 8 Jul 2026
  • Infectious agents and cancer
Dynamic, transition and variation of cervicovaginal microbiome and HPV infection and cervical dysplasia and cancer: a systematic review.
  • 7 Jul 2026
  • Infectious agents and cancer
Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings.
  • 6 Jul 2026
  • Infectious agents and cancer
CD44 expression associates with EBV LMP1, reduced CD8⁺ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma.
  • 29 Jun 2026
  • Infectious agents and cancer
Mechanistic interactions between Plasmodium falciparum and Epstein-Barr virus in endemic Burkitt Lymphoma pathogenesis: a narrative review (2010-2026).
  • 15 Jul 2026
  • Infectious agents and cancer
HIV-associated malignancies in Tunisia: a 30-year retrospective cohort study from a North African perspective.
  • 14 Jul 2026
  • Infectious agents and cancer
Diverse non-vaccine high-risk HPV genotypes in rural Kerala: implications for cervical cancer prevention in an underserved population.
  • 8 Jul 2026
  • Infectious agents and cancer
Dynamic, transition and variation of cervicovaginal microbiome and HPV infection and cervical dysplasia and cancer: a systematic review.
  • 7 Jul 2026
  • Infectious agents and cancer
Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings.
  • 6 Jul 2026
  • Infectious agents and cancer
CD44 expression associates with EBV LMP1, reduced CD8⁺ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma.
  • 29 Jun 2026
  • Infectious agents and cancer

FAQs on Infectious Agents and Cancer